Seach Medical Group is an Israeli company and has been active in the medical cannabis space since 2008 and was established by the Sarid family, a 3rd generation agriculturalists. When learning about their father’s medical condition they understood the positive influences cannabis can have on a range of illnesses.
The company has a genetic bank with over 500 strains.
CLINICAL TRIALS: Yes
FACILITIES:
IMC-GMP: The company owns and operates an IMC-GMP certified manufacturing & packaging facility.
EU-GMP Capability: The company is capable of supplying EU-GMP certified products via a partner manufacturer.
OWNERSHIP:
Eybna Technologies – 39,5%
R&D company focused on terpenes. The company develops and manufactures natural terpene formulations for use in the cannabis, food, cosmetics and pharmaceutical industries. Eybna is funding and conducting academic research at the Hebrew University and Bar Ilan University in Israel.
Trichome Shell – 41,6%
Develops consumer products which are fully repeatable per unit of product and they hold patents on their manufacturing methods with products sold in the US and Europe. The company offers moodpicks which are smokable cannabis toothpicks filled with CBD and power powder which is a drink-soluble cannabis powder with CBD.
Targene Advanced Technologies – 52.3%
The company produces cannabinoids and cannabis cells by using a liquid medium environment for pharmagrade production of API’s. It is also using gene editing for improvement of plant traits such as the resistance of fungi, change in the composition of cannabionids and increased yield.
PlantArc Bio – 6,9%
The company owns 42.3% of Targene Advanced Technologies and has a patented technology called DIP for the discovery of genes that has positive effects on plants. The company has found genes which help increase yield, drought resistance and herbicide tolerance which the company has started to commercialize to leading global seed companies.
Sarrio Hellas in Greece cultivates, processes and sells medical cannabis. – 52,5%
Green Element in Netherlands – 40%
NEWS & PARTNERSHIPS:
2020
The company was the first time commercial exporter of medical cannabis from Israel.
2021
The company executed the largest scale commercial export from an Israeli company with 120 kg of flower to Australia.
The company entered into a deal with Cannatrek becoming the sole supplier of EU GMP-compliant medicinal cannabis to Cannatrek from Israel.
BRANDS:
Nitzan is Seach Medical Group’s GMP and IMC-GMP-compliant home brand offering flowers and oils in different THC and CBD ratios.